Eagle Pharmaceuticals Inc expected to post earnings of $1.05 a share - Earnings Preview

Eagle Pharmaceuticals

04/08/2023 19:38

* Eagle Pharmaceuticals Inc  EGRX.OQ   EGRX.O  is expected
to show
a fall in quarterly revenue when it reports  results on August
8. 
    * The Woodcliff Lake New Jersey-based  company is expected
to
report  a 19.9% decrease in revenue to $59.365 million from
$74.14 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Eagle
Pharmaceuticals Inc
is for earnings of $1.05 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $26​, above​ its last closing price
of $21.17. ​​​

This summary was machine generated August 4 at 18:36 GMT.  All
figures in US dollars  unless otherwise stated